Encompass Health's (EHC) Shares Up 3% on Q4 Earnings Beat

04:26pm, Friday, 10'th Feb 2023 Zacks Investment Research
Encompass Health's (EHC) fourth-quarter results reflect growing patient volumes and reimbursement rates. Management expects 2023 adjusted EPS within $2.87-$3.16, higher than $2.85 in 2022.

Why Cano Health Stock Moved Up This Week

06:43pm, Thursday, 09'th Feb 2023 The Motley Fool
The buyout of a competitor fueled a rise in the primary medical-care company's shares this week.
The acquisition will provide new revenue at a time when growth in the company's legacy pharmacy and retail businesses is expected to slow down.

Here is What to Know Beyond Why Humana Inc. (HUM) is a Trending Stock

02:00pm, Wednesday, 08'th Feb 2023 Zacks Investment Research
Humana (HUM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Humana (HUM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Ensign Group (ENSG) Shares Down 2% Since Q4 Earnings Release

04:17pm, Monday, 06'th Feb 2023 Zacks Investment Research
Ensign Group's (ENSG) fourth-quarter results indicate higher skilled services revenue and improved occupancies, partly offset by the increased cost of services.
Citigroup boosted the price target for RH (NYSE: RH) from $305 to $380. Citigroup analyst Steven Zaccone maintained a Buy rating. Hershey shares fell 4% to $330.00 in pre-market trading. Mizuho cut t

Cigna (CI) Q4 Earnings Top on U.S. Commercial Unit, Dividend Up

06:03pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Cigna's (CI) fourth-quarter results reflect the strong contribution from the Evernorth segment. Management sanctions a 10% increase in the quarterly dividend.

Analyst Expectations for Humana's Future

05:00pm, Thursday, 02'nd Feb 2023 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Humana (NYSE:HUM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's b
Humana's stock was down 3.3% in trading on Thursday, while shares of UnitedHealth Group, Elevance Health and Cigna Corp. also fell.
Keefe, Bruyette & Woods boosted the price target for Evercore Inc. (NYSE: EVR) from $132.5 to $137. Keefe, Bruyette & Woods analyst Matthew Moon maintained an Outperform rating. Evercore shares rose
The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging. Meta Platform Inc’s (NASDAQ: META) strong earnings could set the tempo for the market mood as tr
A proposal for lower-than-expected Medicare Advantage rates in 2024 has sent shares of publicly traded health insurers falling.

Humana (HUM) Reports Q4 Earnings: What Key Metrics Have to Say

08:22am, Thursday, 02'nd Feb 2023 Zacks Investment Research
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE